Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-19 12:23 pm Purchase | 2025-09-12 | 13G | BIOCRYST PHARMACEUTICALS INC BCRX | Flynn James E | 12,169,000 5.800% | 5,793,857 (+90.88%) | Filing History |
| 2025-08-22 4:07 pm Sale | 2025-08-22 | 13G | BROOKDALE SENIOR LIVING INC CO BKD | Flynn James E | 11,637,032 4.900% | -3,725,232 (-24.25%) | Filing History |
| 2025-08-18 5:59 pm Purchase | 2025-08-11 | 13G | BRIDGEBIO ONCOLOGY THERAPEUTIC BBOT | Flynn James E | 4,885,446 6.170% | 4,885,446 (New Position) | Filing History |
| 2025-08-14 08:19 am Purchase | 2025-06-30 | 13G | BROOKDALE SENIOR LIVING INC CO BKD | Flynn James E | 15,362,264 6.470% | 569,000 (+3.85%) | Filing History |
| 2025-08-01 6:06 pm Sale | 2025-07-30 | 13D | ARS PHARMACEUTICALS, INC SPRY | Flynn James E | 7,610,217 7.750% | -1,023,320 (-11.85%) | Filing History |
| 2025-07-31 6:26 pm Purchase | 2025-07-31 | 13D | LARIMAR THERAPEUTICS INC LRMR | Flynn James E | 30,667,474 35.810% | 9,394,000 (+44.16%) | Filing History |
| 2025-07-22 7:38 pm Sale | 2025-07-18 | 13D | ARS PHARMACEUTICALS, INC SPRY | Flynn James E | 8,633,537 8.790% | -1,090,971 (-11.22%) | Filing History |
| 2025-07-11 08:19 am Purchase | 2025-07-07 | 13G | COGENT BIOSCIENCES INC COGT | Flynn James E | 9,053,118 6.490% | 6,086,773 (+205.19%) | Filing History |
| 2025-07-02 08:24 am Sale | 2025-07-02 | 13D | ARS PHARMACEUTICALS, INC SPRY | Flynn James E | 9,724,508 9.900% | -790,149 (-7.51%) | Filing History |
| 2025-06-11 5:38 pm Purchase | 2025-06-06 | 13G | VERA THERAPEUTICS INC VERA | Flynn James E | 3,348,117 5.250% | 3,348,117 (New Position) | Filing History |
| 2025-05-13 8:50 pm Sale | 2025-03-31 | 13G | ACCENDRA HEALTH INC ACH | Flynn James E | 0 0.000% | -5,229,779 (Position Closed) | Filing History |
| 2025-05-13 8:50 pm Purchase | 2025-03-31 | 13G | INDIVIOR PLC USD0.5 INDV | Flynn James E | 10,567,160 8.470% | 1,684,000 (+18.96%) | Filing History |
| 2025-05-13 8:50 pm Sale | 2025-03-31 | 13G | EMBECTA CORP COM EMBC | Flynn James E | 2,720,535 4.660% | -354,800 (-11.54%) | Filing History |
| 2025-05-13 8:49 pm Sale | 2025-03-31 | 13G | MALLINCKRODT PLC SHS MNKTQ | Flynn James E | 804,259 4.070% | -655,974 (-44.92%) | Filing History |
| 2025-03-24 7:57 pm Sale | 2025-03-20 | 13D | ARS PHARMACEUTICALS, INC SPRY | Flynn James E | 10,514,657 10.720% | -563,270 (-5.08%) | Filing History |
| 2025-03-03 7:04 pm Unchanged | 2025-02-27 | 13D | BIOMX INC PHGE | Flynn James E | 818,866 9.990% | 0 (Unchanged) | Filing History |
| 2025-02-25 9:18 pm Sale | 2025-02-21 | 13D | SINGULAR GENOMICS SYS INC OMIC | Flynn James E | 1,000 100.000% | -248,495 (-99.60%) | Filing History |
| 2025-02-13 09:40 am Sale | 2025-02-13 | 13G | DOCGO INC DCGO | Flynn James E | 5,051,500 4.950% | -4,014,638 (-44.28%) | Filing History |
| 2025-02-13 09:39 am Purchase | 2024-12-31 | 13G | INDIVIOR PLC USD0.5 INDV | Flynn James E | 8,883,160 7.160% | 1,519,950 (+20.64%) | Filing History |
| 2025-02-13 08:59 am Sale | 2024-12-31 | 13G | VENTYX BIOSCIENCES INC VTYX | Flynn James E | 534,737 0.760% | -6,180,764 (-92.04%) | Filing History |